PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Cough D003371 19 associated lipids
Cryptococcosis D003453 3 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dehydration D003681 11 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Keenan CM and Rangachari PK Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. 1991 Am. J. Physiol. pmid:2003610
Roberts LJ and Oates JA Biochemical diagnosis of systemic mast cell disorders. 1991 J. Invest. Dermatol. pmid:16799604
Massey WA et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. 1991 Br. J. Dermatol. pmid:1760357
Sinzinger H et al. Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. 1991 Am. J. Hematol. pmid:1899965
Tasaki Y et al. Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. 1991 Prostaglandins pmid:1871375
Hori T et al. Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. 1991 Biochem. Biophys. Res. Commun. pmid:1993070
Marui N et al. Delta 12-prostaglandin J2 mimics heat shock in inducing cell cycle arrest at G1 phase. 1991 Biochem. Biophys. Res. Commun. pmid:1930204
Nakajima M et al. Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans. 1991 Graefes Arch. Clin. Exp. Ophthalmol. pmid:1937072
Perreault T and De Marte J Endothelin-1 has a dilator effect on neonatal pig pulmonary vasculature. 1991 J. Cardiovasc. Pharmacol. pmid:1719291
van der Donk EM et al. Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:1719566
Murakami M et al. Group II phospholipase A2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells. 1991 Biochem. Biophys. Res. Commun. pmid:1721808
Myers AC et al. Influence of antigen on membrane properties of guinea pig bronchial ganglion neurons. 1991 J. Appl. Physiol. pmid:1721906
Stellato C et al. General anaesthetics induce only histamine release selectively from human mast cells. 1991 Br J Anaesth pmid:1722691
Walmrath D et al. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. 1991 J. Appl. Physiol. pmid:1723406
Alvarez R et al. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin. 1991 Prostaglandins pmid:1775633
Orfan N et al. Systemic cold urticaria in a five-year-old boy. 1991 Ann Allergy pmid:1867452
Koizumi T et al. Induction of a 31,000-dalton stress protein by prostaglandins D2 and J2 in porcine aortic endothelial cells. 1991 Biochem. Pharmacol. pmid:1867634
Bulbena O et al. Mast cells in the rat gastric mucosa are not primarily responsible for PGD2 generation. 1991 Prostaglandins pmid:1871377
Shiozaki M et al. Synthesis of 2-deoxy-2-[(2,2-difluoro-3-hydroxytetradecanoyl)amino]-3-O- [(R)-3-(tetradecanoyloxy)tetradecanoyl]-D-glucopyranose 4-phosphate. 1991 J. Med. Chem. pmid:1875354
Inoue M et al. Interactions between brain acetylcholine and prostaglandins in control of vasopressin release. 1991 Am. J. Physiol. pmid:1877699
Francis HP et al. BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig. 1991 Br. J. Pharmacol. pmid:1797323
Jongejan R et al. Effect of epithelial denudation, inflammatory mediators and mast cell activation on the sensitivity of isolated human airways to methacholine. 1991 Eur. J. Pharmacol. pmid:1800116
Woodward DF et al. Studies on leukotriene D4 as an eosinophil chemoattractant. 1991 Drugs Exp Clin Res pmid:1841046
Walls AF et al. Inflammatory mediators and cellular infiltration of the lungs in a guinea pig model of the late asthmatic reaction. 1991 Lung pmid:1921474
Crivellari MT et al. Eicosanoid release and mepyramine, LTC4 and LTD4 binding in passively sensitized human lung parenchyma in vitro. 1991 Biochem. Pharmacol. pmid:1859453
Francis HP et al. The thromboxane receptor antagonist BAY u3405 reverses prostaglandin D2 (PGD2)-induced bronchoconstriction in the anaesthetised guinea pig. 1991 Ann. N. Y. Acad. Sci. pmid:1835329
Kobayashi Y et al. Syntheses of 2,6-dideoxy-6-fluoro-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]-D- glucopyranose 4-(dihydrogen phosphate) and 2-deoxy-2-[(3R and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra decanoyl]- alpha-D-glucopyranosyl fluoride 4-(dihydrogen phosphate): fluorosugar analogues of GLA-60. 1991 Carbohydr. Res. pmid:1813114
Ney P and Schrör K PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. 1991 Eicosanoids pmid:1647806
Gundel RH et al. Antigen-induced mediator release in primates. 1991 Am. Rev. Respir. Dis. pmid:1648317
Marriott DR et al. Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. 1991 J. Neurochem. pmid:1702831
Smith GS et al. Adaptive cytoprotection against alcohol injury in the rat stomach is not due to increased prostanoid synthesis. 1991 Prostaglandins pmid:1906621
Conde B et al. Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6. 1991 Jan-Feb Anticancer Res. pmid:1902073
Lundin-Schiller S and Mitchell MD Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. 1991 Jul-Aug Placenta pmid:1946245
Naclerio RM Additional properties of cetirizine, a new H1 antagonist. 1991 May-Jun Allergy Proc pmid:1680095
van der Linden PW et al. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. 1992 J. Allergy Clin. Immunol. pmid:1629497
Thomas PS et al. Tobacco smoke releases performed mediators from canine mast cells and modulates prostaglandin production. 1992 Am. J. Physiol. pmid:1636731
Sasaguri T et al. Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. 1992 Exp. Cell Res. pmid:1572402
Sinzinger H et al. Isradipine improves platelet function in hypertensives. 1992 Eur. J. Clin. Pharmacol. pmid:1531796
Ito S et al. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. 1992 Glia pmid:1324890
Tsukagoshi H and Kurosawa M [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. 1992 Nippon Yakurigaku Zasshi pmid:1559641
Magnussen H et al. Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. 1992 J. Allergy Clin. Immunol. pmid:1535083
Gaetani P et al. Ex vivo release of eicosanoids after aneurysmal subarachnoid hemorrhage: a preliminary experience in humans. 1992 Acta Neurol. Scand. pmid:1414230
Stellato C et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1373749
Katz HR et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. 1992 J. Immunol. pmid:1309842
Morrow JD et al. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. 1992 J. Invest. Dermatol. pmid:1373750
Okayama Y et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. 1992 Clin. Exp. Allergy pmid:1375128
Okayama Y and Church MK Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. 1992 Int. Arch. Allergy Immunol. pmid:1375203
Smith JB et al. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. 1992 Biochem. J. pmid:1375452
Ikai K et al. Induction of 72-kD heat shock protein and cytoskeleton damage by cytotoxic prostaglandin delta 12-PGJ2 in transformed human epidermal cells in culture. 1992 J. Invest. Dermatol. pmid:1375619
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Lippton HL et al. Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. 1992 Am. J. Physiol. pmid:1348400
Crea AE et al. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. 1992 Eur. Respir. J. pmid:1348480
Shin MH et al. The effect of azelastine on the early allergic response. 1992 Clin. Exp. Allergy pmid:1349259
Molderings G et al. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. 1992 Br. J. Pharmacol. pmid:1330175
Mulkins MA et al. Mycophenolic acid inhibits the degranulation of rat peritoneal mast cells. 1992 Cell. Immunol. pmid:1349511
Conti P et al. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release. 1992 Immunol. Lett. pmid:1612634
Liu H et al. Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide. 1992 J. Biol. Chem. pmid:1328211
González-Utor AL et al. Cytochemical localization of K(+)-dependent p-nitrophenyl phosphatase and adenylate cyclase by using one-step method in human washed platelets. 1992 Histochemistry pmid:1330994
Raible DG et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. 1992 J. Immunol. pmid:1588043
Amici C et al. Inhibition of Sendai virus replication by delta 12-prostaglandin J2: induction of heat shock protein synthesis and alteration of protein glycosylation. 1992 Antiviral Res. pmid:1332600
Seregi A et al. Functionally diverse purinergic P2Y-receptors mediate prostanoid synthesis in cultured rat astrocytes: the role of ATP-induced phosphatidyl-inositol breakdown. 1992 Eicosanoids pmid:1333251
Björnsson OG et al. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. 1992 J. Lipid Res. pmid:1331281
Knani J et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. 1992 J. Allergy Clin. Immunol. pmid:1334102
Stellato C et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. 1992 Anesthesiology pmid:1280014
de Paulis A et al. Anti-inflammatory effect of FK-506 on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1281861
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
Morii H and Watanabe Y A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex. 1992 Arch. Biochem. Biophys. pmid:1309289
Wang JP et al. Anti-inflammatory and analgesic effects of magnolol. 1992 Naunyn Schmiedebergs Arch. Pharmacol. pmid:1336574
Kuchinke W et al. A lung type prostaglandin F synthase is expressed in bovine liver: cDNA sequence and expression in E. coli. 1992 Biochem. Biophys. Res. Commun. pmid:1339268
Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. 1992 J. Immunol. pmid:1378071
Goerg KJ et al. Inhibition of neuronally mediated secretion in rat colonic mucosa by prostaglandin D2. 1992 Gastroenterology pmid:1379954
Charlesworth EN et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. 1992 J. Pharmacol. Exp. Ther. pmid:1382132
Murakami M et al. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. 1992 Eur. J. Biochem. pmid:1382985
Johnston SL et al. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. 1992 Br J Clin Pharmacol pmid:1467134
Lin CH et al. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. 1992 Thromb. Res. pmid:1412184
Bacic F et al. Prostaglandin D2 in cultured capillary and microvascular endothelium of human brain. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1508957
Thomas PS et al. Prostaglandin D2 production and identification of prostaglandin H synthase within canine mast cell granule. 1992 Am. J. Physiol. pmid:1514641
Kaiser L et al. Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? 1992 Exp. Parasitol. pmid:1516664
Braun M and Schrör K Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. 1992 Circ. Res. pmid:1385004
Emery BE et al. The effect of IL-4 on human nasal mucosal responses. 1992 J. Allergy Clin. Immunol. pmid:1430703
Barrett KE Effect of histamine and other mast cell mediators on T84 epithelial cells. 1992 Ann. N. Y. Acad. Sci. pmid:1456653
Diener M et al. Characterization of the antisecretory action of prostaglandin D2 in the rat colon. 1992 Acta Physiol. Scand. pmid:1502910
Virgolini I et al. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. 1992 J. Biol. Chem. pmid:1377673
Watanabe-Kohno S et al. MCI-826 is a potent and selective antagonist of peptide leukotrienes (p-LTs) and has characteristics distinctive from those of FPL 55712. 1992 Jpn. J. Pharmacol. pmid:1460800
Baumgarten CR et al. Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammation. 1992 Agents Actions Suppl. pmid:1462881
Ellis JL and Undem BJ Antigen-induced enhancement of noncholinergic contractile responses to vagus nerve and electrical field stimulation in guinea pig isolated trachea. 1992 J. Pharmacol. Exp. Ther. pmid:1323657
Tamaoki J et al. Prostaglandin D2 increases Cl secretion across canine tracheal epithelium through cyclo-oxygenase stimulation and cAMP production. 1992 Acta Physiol. Scand. pmid:1323920
Froldi M et al. Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. 1992 J. Neuroimmunol. pmid:1315794
Fukushima M Biological activities and mechanisms of action of PGJ2 and related compounds: an update. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1438462
Shimakura S and Boland CR Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. 1992 Cancer Res. pmid:1551103
Ninomiya H et al. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. 1992 Prostaglandins pmid:1584994
Lee DY et al. Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. 1992 Prostaglandins pmid:1542741
Picado C et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. 1992 Am. Rev. Respir. Dis. pmid:1309968
Kawada N et al. Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. 1992 Gastroenterology pmid:1499903
Koizumi T et al. Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. 1992 Prostaglandins pmid:1542739
Rangachari PK Concerning prostaglandin D2: forgotten, promiscuous, capricious. 1992 Ann. N. Y. Acad. Sci. pmid:1456655
Krueger JM et al. Prostaglandins E2 and D2 have little effect on rabbit sleep. 1992 Physiol. Behav. pmid:1523224
D'Onofrio C et al. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. 1992 Int. J. Cancer pmid:1592539
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Hogaboam CM et al. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. 1992 Br. J. Pharmacol. pmid:1596692